Actualités Vion Pharmaceuticals Inc. (MM) - VIOND | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Vion Pharmaceuticals Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO...

Vion Pharmaceuticals Inc - Statement of Ownership (SC 13G)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3...

Vion Pharmaceuticals Inc - Annual Report (10-K)

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K...

Vion Reports 2007 Fourth Quarter and Year-End Results

NEW HAVEN, Conn., March 17 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (NASDAQ:VIOND) today announced financial results for the fourth...

Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results

NEW HAVEN, Conn., March 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (NASDAQ:VIOND) today announced that it would hold a conference...

Vion Pharmaceuticals Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO...

Vion Pharmaceuticals Regains NASDAQ Listing Compliance

NEW HAVEN, Conn., March 7 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (Nasdaq Capital Market: VION) today announced that it had...

Vion Pharmaceuticals Inc - Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO...

Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split

NEW HAVEN, Conn., Feb. 20 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (NASDAQ:VION) today announced that the Company would implement a...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Vion Pharmaceuticals Inc. (MM) (VIOND)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

VIOND Actualités

Vion Pharmaceuticals Inc - Current report filing (8-K)

Vion Pharmaceuticals Inc - Statement of Ownership (SC 13G)

Vion Pharmaceuticals Inc - Annual Report (10-K)

Vion Reports 2007 Fourth Quarter and Year-End Results

Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results

Vion Pharmaceuticals Inc - Current report filing (8-K)

Vion Pharmaceuticals Regains NASDAQ Listing Compliance

Vion Pharmaceuticals Inc - Current report filing (8-K)

Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Vion Pharmaceuticals Inc. (MM) (VIOND) Actualités

Vion Pharmaceuticals Inc. (MM) (VIOND)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

VIOND Actualités

Vion Pharmaceuticals Inc - Current report filing (8-K)

Vion Pharmaceuticals Inc - Statement of Ownership (SC 13G)

Vion Pharmaceuticals Inc - Annual Report (10-K)

Vion Reports 2007 Fourth Quarter and Year-End Results

Vion Pharmaceuticals to Host Conference Call to Discuss 2007 Fourth Quarter and Year-End Financial Results

Vion Pharmaceuticals Inc - Current report filing (8-K)

Vion Pharmaceuticals Regains NASDAQ Listing Compliance

Vion Pharmaceuticals Inc - Current report filing (8-K)

Vion Pharmaceuticals to Implement a One-for-Ten Reverse Stock Split

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités